LINC01866

Across TCGA pan-cancer cohorts, LINC01866 RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated LINC01866 data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher LINC01866 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated LINC01866 expression acts as an unfavorable survival marker, although some lineages such as HNSC and LUSC show a favorable association.

HNSC, STAD, and UCEC are the cancer types where LINC01866 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Tertile	III,IV	0.810	0.542	.002	117	view →
STAD	OS	Tertile	IV	0.106	0.533	.006	54	view →
UCEC	OS	Tertile	All	0.762	0.928	.001	54	view →
LIHC	OS	Tertile	All	0.352	0.531	.002	54	view →
LUAD	DFS	Tertile	IV	0.448	0.936	<.001	18	view →
READ	DFS	Tertile	III,IV	0.082	0.760	.001	9	view →
SARC	DFS	Tertile	All	0.223	0.607	.001	9	view →
LUSC	DFS	Tertile	II,III,IV	0.901	0.686	.048	3	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

LINC01866–HNSC (DFS)

Open the HNSC breakdown →